Clinical Trial Update: Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a treatment for breakthrough pain in opioid-tolerant cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Cephalon | Conditions: Pain, Cancer | Phase 3 | Status: COMPLETED